STENOCARE PRODUCT APPROVED AND READY FOR SALE IN GERMANY
STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provided by the contact person below for publication on May 25, 2023. The new Stenocare medical cannabis oil product has received approval from the Federal Institute for Drugs and...
Dela artikeln
Taggar: stenocare, product, approved
Läs vidare på Dagens IndustriRelaterade nyheter
- STENOCARE företrädesemission med Units – startar i dag
- STENOCARE A/S: Unit Rights Issue of up to 29.7 mDKK
- STENOCARE A/S (“Stenocare”) delivered products to its 5 markets during Q4 2022 corresponding to net sales of 2.8 mDKK and is on track for its...
- Stenocares förlust ökar
- Stenocare accesses the Norwegian market. Stenocare has signed a distribution agreement with the leading distributor and pharmacy chain.
Fler ekonominyheter
- STENOCARE företrädesemission med Units – startar i dag
- STENOCARE A/S: Unit Rights Issue of up to 29.7 mDKK
- STENOCARE A/S (“Stenocare”) delivered products to its 5 markets during Q4 2022 corresponding to net sales of 2.8 mDKK and is on track for its...
- Stenocares förlust ökar
- Stenocare accesses the Norwegian market. Stenocare has signed a distribution agreement with the leading distributor and pharmacy chain.